Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

Genetics and ulcerative colitis: What are the clinical implications?

Academic Article
Publication Date:
2011
Short description:
Genetics and ulcerative colitis: What are the clinical implications? / Latiano, A., Annese, V.. - In: CURRENT DRUG TARGETS. - ISSN 1389-4501. - 12:10(2011), pp. 1383-1389. [10.2174/138945011796818171]
abstract:
Substantial progress has been made in the last years in characterizing the susceptibility genes involved in IBD pathogenesis, especially for Crohn's disease. Although some genetic factors associated with Crohn's disease also predispose individuals to ulcerative colitis, markers specific only for ulcerative colitis have been found. Recent genomewide association studies in ulcerative colitis have identified several new loci, and suggested many new potential pathways. The identified susceptibility genes and their variants could be useful to predict disease course and to improve stratification of patients, when correlated with other subphenotypes. Moreover, understanding the biological pathways involved in the disease could lead to the development of new treatments and molecules that specifically target such pathways, discover different therapeutic approaches and eventually progress to personalized treatment. © 2011 Bentham Science Publishers Ltd.
Iris type:
1.1.1 Articolo in rivista - Review
Keywords:
Crohn's disease; Genome-wide association studies; Inflammatory bowel disease; Single nucleotide polymorphism; Therapy; Ulcerative colitis
List of contributors:
Latiano, A.; Annese, V.
Authors of the University:
ANNESE VITO
Handle:
https://iris.unisr.it/handle/20.500.11768/172833
Published in:
CURRENT DRUG TARGETS
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.2.0